CRISPR-Mediated In Situ Introduction or Integration of F9-Padua in Human iPSCs for Gene Therapy of Hemophilia B

Qiyu Tang(Roslin Institute), Desheng Liang(Central South University)

International Journal of Molecular Sciences

May 19, 2023

10.3390/ijms24109013

Cited by 8

Related Papers

<scp>TGF‐β</scp>‐induced <scp>PI3K</scp>/<scp>AKT</scp>/<scp>mTOR</scp> pathway controls myofibroblast differentiation and secretory phenotype of valvular interstitial cells through the modulation of cellular senescence in a naturally occurring in vitro canine model of myxomatous mitral valve disease

|Cell Proliferation|2023|64

Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci

|Oncotarget|2017|26

Mesenchymal stem cells derived from iPSCs expressing interleukin-24 inhibit the growth of melanoma in the tumor-bearing mouse model

|Cancer Cell International|2020|20

iPSC‐derived NK cells with site‐specific integration of CAR19 and IL24 at the multi‐copy rDNA locus enhanced antitumor activity and proliferation

|MedComm|2024|6

Identification of the Efficient Enhancer Elements in FVIII-Padua for Gene Therapy Study of Hemophilia A

|International Journal of Molecular Sciences|2024|3